Skip Navigation Links Home : Details
             
Name : Faisal Al-Akayleh

Academic Rank: Assistant Professor

Administrative Position : Faculty Academic Member

Office 8303       Ext No 537

Email : falakayleh@uop.edu.jo

Specialization: Pharmaceutics

Graduate Of: University of Baghdad

Qualification

    Qualification

    University

    Country

    Year

    Bachelor
    Jordan University
    Jordan
    1994
    Master's
    Baghdad
    Iraq
    1998
    Ph.D
    University of Baghdad
    Iraq
    2004



  • Journal Paper





      Rana Al-Shaikh Hamid, " Evaluation of Three Chitin Metal Silicate Co-precipitates as a Potential Multifunctional Single Excipient in Tablet Formulations " , "Marine Drugs",Vol.8,No.1660-3397, , , 10/25/2010 Abstract:
      The performance of the novel chitin metal silicate (CMS) co-precipitates as a single multifunctional excipient in tablet formulation using direct compression and wet granulation methods is evaluated. The neutral, acidic, and basic drugs Spironolactone (SPL), ibuprofen (IBU) and metronidazole (MET), respectively, were used as model drugs. Commercial Aldactone®, Fleximex® and Dumazole® tablets containing SPL, IBU and MET, respectively, and tablets made using Avicel® 200, were used in the study for comparison purposes. Tablets of acceptable crushing strength (>40 N) were obtained using CMS. The friability values for all tablets were well below the maximum 1% USP tolerance limit. CMS produced superdisintegrating tablets (disintegration time < 1 min) with the three model drugs. Regarding the dissolution rate, the sequence was as follow: CMS > Fleximex® > Avicel® 200, CMS > Avicel® 200 > Dumazole® and Aldactone® > Avicel® 200 > CMS for IBU, MET and SPL, respectively. Compressional properties of formulations were analyzed using density measurements and the compression Kawakita equation as assessment parameters. On the basis of DSC results, CMS co precipitates were found to be compatible with the tested drugs. Conclusively, the CMS co-precipitates have OPEN ACCESS Mar. Drugs 2010, 8 1700 the potential to be used as filler, binder, and superdisintegrant, all-in-one, in the design of tablets by the direct compression as well as wet granulation methods.




      Faisal Al-Akayleh, M, " Formulation and In vitro assessment of sustained release terbutaline sulfate tablet made from binary hydrophilic polymer mixtures. " , "Pharmaceutical Development and Technology",Vol.4,No.5, Informa Healthcare, London, 10/06/2011 Abstract:
      In the present systematic study, a sustained release of terbutaline sulfate tablet (TBS) was developed and optimized by employing the hydrophilic polymers; chitosan and xanthan gum mixed with sodium bicarbonate as a release modifying agent. This formulation was developed using direct compression technology. In vitro release studies indicated rapid swelling and drug release in the initial period of the acid stage from a matrix composed of chitosan and xanthan gum solely. Addition of sodium bicarbonate to the matrix resulted in sustained drug release. Various formulation factors such as polymer to polymer ratio, polymer viscosity and particle size were altered and their effect on dissolution pattern was illustrated. Manufacturing variables such as compression force and lubricant percentage were investigated and found not to influence the drug release profile of the resulted tablets. The release mechanism follows Korsmeyer-Peppas equation with n value indicating non-Fickian diffusion. The release profiles were analyzed using statistical method (one-way ANOVA) and f(2) metric values and found to be similar to the commercial product Bricanyl(®). Reproducible data were obtained when scale-up of the formulation was performed.






  • Master Thesis





      Rana Al-Shaikh Hame, " EVALUATION OF CHITIN METAL SILICATE CO PRECIPITATES AS POTENTIAL MULTIFUNCTIONAL EXCIPIENTS IN TABLET FORMULATIONS " , "",Vol.,No., , , 06/15/2010




      Ruaa Al-Ajeeli, Dr. , " Formulation and in Vitro/ in Vivo Evaluation of In-Situ Gel Matrix System for Sustaining the Release of Paractamol " , "",Vol.,No., , , 01/15/2010
  • Event Calendar
    <October 2017>
    SunMonTueWedThuFriSat
    1234567
    891011121314
    15161718192021
    22232425262728
    293031